Details for 2018214077

Up to date per 01.04.2026

Actions

Title / Product Name

GENETISCH MODIFIZIERTE NICHTMENSCHLICHE TIERE ZUR EXPRESSION VON MENSCHLICHEM EPO

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018214077

EP Publication Number

3482629

E-Number

1337220

Language

PCT Number

Publication Date

15.05.2019 A

25.11.2020 B1

Registration Date

25.11.2020

AT Publication Date

15.12.2020

Application Date

18.05.2015

Registration Number

Priorities

19.05.2014

201462000460 P

IPC

A01K 67/027 20060101AFI20190214BHEP

Maximum Duration of Protection

18.05.2035

Owner

Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River Road Tarrytown, NY 10591-6707US

Yale UniversityTwo Whitney Avenue New Haven, CT 06510US

Institute for Research in Biomedicine (IRB)Via Vincenzo Vela 6, 6501 BellinzonaCH

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

MURPHY, Andrew J.c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, CT 10591US

STEVENS, Sean12848 Caminito De Las Olas Del Mar, CT 92014US

FLAVELL, Richard283 Moose Hill Road Guilford, CT 06437US

MANZ, MarkusDirektor Klinik für Hämatologie Universitätsspital Zürich Raemistrasse 100 8091 ZürichCH

SHAN, Liang432 Carswold Drive St. Louis, MO 63105US

Information about Fees